FOLH1 and glioblastoma: Wernicke et al (6) and Nomura et al (7) reported PSMA immunoreactivity in the neovasculature of all glioblastoma specimens tested, although they discuss that an earlier study had found that glioblastoma specimens were negative for PSMA expression.